The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concomitant administration of multiple hepatotoxic drugs has also been associated with an increased risk of DILI in several studies.40–43”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Association of Acetaminophen Hepatotoxicity With Fasting and Ethanol Use
Whitcomb, D. C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520230055038 · Cited by 470
Research works printed but not linked: 42
- Lee, 2007, Acetaminophen toxicity: changing perceptions on a social/medical issue, Hepatology, 46, 966, 10.1002/hep.21926 · DOI
- Schiodt, 1999, Etiology and outcome for 295 patients with acute liver failure in the United States, Liver Transpl Surg, 5, 29, 10.1002/lt.500050102 · DOI · Paper page
- Kuffner, 2001, Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial, Arch Intern Med, 161, 2247, 10.1001/archinte.161.18.2247 · DOI
- Larson, 2005, Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study, Hepatology, 42, 1364, 10.1002/hep.20948 · DOI · Paper page
- Myers, 2008, Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose, Clin Gastroenterol Hepatol, 6, 918, 10.1016/j.cgh.2008.02.053 · DOI
- Schmidt, 2002, Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity, Hepatology, 35, 876, 10.1053/jhep.2002.32148 · DOI · Paper page
- Mehendale, 2005, Tissue repair: an important determinant of final outcome of toxicant-induced injury, Toxicol Pathol, 33, 41, 10.1080/01926230590881808 · DOI · Paper page
- Cai, 2000, Lovastatin decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats, J Hepatol, 32, 67, 10.1016/S0168-8278(00)80191-9 · DOI
- Demirbilek, 2007, Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis, Pediatr Surg Int, 23, 155, 10.1007/s00383-006-1829-y · DOI
- Lai, 2008, Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction, Transplantation, 85, 732, 10.1097/TP.0b013e3181664e70 · DOI
- Tokunaga, 2008, Beneficial effects of fluvastatin on liver microcirculation and regeneration after massive hepatectomy in rats, Dig Dis Sci, 53, 2989, 10.1007/s10620-008-0241-y · DOI
- Ramalho, 2002, Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats, Hepatogastroenterology, 49, 1347
- Yayama, 2007, Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors, Biol Pharm Bull, 30, 591, 10.1248/bpb.30.591 · DOI
- Clement, 2005, Protection against paracetamol-induced hepatic injury by prazosin pre-treatment in CD-1 mice, Mutat Res, 579, 182, 10.1016/j.mrfmmm.2005.03.028 · doi:10.1016/j.mrfmmm.2005.03.028
- Oben, 2003, Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury, Hepatology, 38, 664, 10.1053/jhep.2003.50371 · DOI
- Reyes-Salcido, 2003, Evidence that dl-propranolol increases thymidine kinase activity, cell mitosis, and beta-adrenoceptors during rat liver regeneration, Arch Med Res, 34, 273, 10.1016/S0188-4409(03)00049-3 · doi:10.1016/s0188-4409(03)00049-3
- Ronsein, 2005, Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver, Redox Rep, 10, 131, 10.1179/135100005X38879 · DOI
- Donthamsetty, 2008, Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate, Toxicol Appl Pharmacol, 230, 327, 10.1016/j.taap.2008.02.031 · DOI
- Mehendale, 2000, PPAR-alpha: a key to the mechanism of hepatoprotection by clofibrate, Toxicol Sci, 57, 187, 10.1093/toxsci/57.2.187 · DOI
- Nicholls-Grzemski, 1992, Peroxisome proliferators protect against paracetamol hepatotoxicity in mice, Biochem Pharmacol, 43, 1395, 10.1016/0006-2952(92)90193-M · DOI
- James, 1993, Phenylpropanolamine potentiation of acetaminophen-induced hepatotoxicity: evidence for a glutathione-dependent mechanism, Toxicol Appl Pharmacol, 118, 159, 10.1006/taap.1993.1021 · doi:10.1006/taap.1993.1021
- Roberts, 1994, Methylphenidate-induced hepatotoxicity in mice and its potentiation by beta-adrenergic agonist drugs, Life Sci, 55, 269, 10.1016/0024-3205(94)00729-2 · doi:10.1016/0024-3205(94)00729-2
- Roberts, 1991, Potentiation of carbon tetrachloride hepatotoxicity by phenylpropanolamine, Toxicol Appl Pharmacol, 111, 175, 10.1016/0041-008X(91)90022-7 · doi:10.1016/0041-008x(91)90022-7
- Oben, 2004, Sympathetic nervous system regulation of liver repair, Anat Rec A Discov Mol Cell Evol Biol, 280, 874, 10.1002/ar.a.20081 · DOI
- Grypioti, 2008, Platelet activating factor (PAF) antagonism with ginkgolide B protects the liver against acute injury, Dig Dis Sci, 53, 1054, 10.1007/s10620-007-9982-2 · DOI
- Nocito, 2007, Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice, Hepatology, 45, 369, 10.1002/hep.21516 · DOI · Paper page
- Maurer-Spurej, 2004, The influence of selective serotonin reuptake inhibitors on human platelet serotonin, Thromb Haemost, 91, 119, 10.1160/TH03-05-0330 · DOI · Paper page
- Begay, 2003, Late administration of COX-2 inhibitors minimize hepatic necrosis in chloroform induced liver injury, Toxicology, 185, 79, 10.1016/S0300-483X(02)00594-2 · doi:10.1016/s0300-483x(02)00594-2
- Beraza, 2005, Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration, Hepatology, 41, 460, 10.1002/hep.20590 · DOI
- Ito, 2003, Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice, Eur Surg Res, 35, 408, 10.1159/000072174 · DOI
- Lesurtel, 2006, Platelet-derived serotonin mediates liver regeneration, Science, 312, 104, 10.1126/science.1123842 · DOI · Paper page
- Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
- Norata, 2003, Statins and oxidative stress during atherogenesis, J Cardiovasc Risk, 10, 181, 10.1097/00043798-200306000-00005 · doi:10.1097/00043798-200306000-00005
- Aviram, 1998, Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation, Atherosclerosis, 138, 271, 10.1016/S0021-9150(98)00032-X · DOI · Paper page
- Lee, 2006, Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways, Chem Biol Interact, 160, 123, 10.1016/j.cbi.2006.01.002 · DOI
- Hsieh, 2004, Akt/PKB and p38 MAPK signaling, translational initiation and longevity in Snell dwarf mouse livers, Mech Ageing Dev, 125, 785, 10.1016/j.mad.2004.07.008 · DOI · Paper page
- Mohr, 2008, Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only, Hepatol Res, 38, 1233, 10.1111/j.1872-034X.2008.00396.x · doi:10.1111/j.1872-034x.2008.00396.x
- Sonntag, 1992, Effects of aging and dietary restriction on tissue protein synthesis: relationship to plasma insulin-like growth factor-1, J Gerontol, 47, B159, 10.1093/geronj/47.5.B159 · DOI
- Yokoyama, 2007, Which gender is better positioned in the process of liver surgery?, Surg Today, 37, 823, 10.1007/s00595-007-3508-6 · DOI
- Jalouli, 2003, Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones, Endocrinology, 144, 101, 10.1210/en.2002-220630 · DOI
- Studer, 1982, Differences between male and female rats in the regulation of hepatic glycogenolysis, J Biol Chem, 257, 7987, 10.1016/S0021-9258(18)34286-8 · DOI
- Rong, 2008, An aqueous extract of Salacia oblonga root, a herb-derived peroxisome proliferator-activated receptor-alpha activator, by oral gavage over 28 days induces gender-dependent hepatic hypertrophy in rats, Food Chem Toxicol, 46, 2165, 10.1016/j.fct.2008.02.022 · DOI
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationIbuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
Drug-induced liver injury: Interactions between drug properties and host factors
Chen, M., Suzuki, A., Borlak, J., Andrade, R. J., & Lucena, M. I. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.016 · Cited by 405
Self-citationAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citation
Metadata
- Authors
- Suzuki, A., Yuen, N., Walsh, J., Papay, J., Hunt, C. M., & Diehl, A. M.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 7
- Issue
- 8
- Pages
- 882-888
- ISSN
- 1542-3565
- Cited by
- 41
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.